A Harvard geneticist told a podcast that human age reversal is ‘in people right now.’ Nearly a million engagements. Almost nobody asked: what molecule, what patients, what endpoint, and what does the regulator actually see?
The most plausible referent is a gene therapy using three Yamanaka reprogramming factors, delivered to retinal ganglion cells, in pa…









